跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
EZETIMIBA/ATORVASTATINA SANDOZ 10 MG/20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
EZETIMIBA/ATORVASTATINA SANDOZ 10 MG/20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Approved
STANDARD
EZETIMIBA/ATORVASTATINA SANDOZ 10 MG/20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Sandoz Farmaceutica S.A.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Dec 9, 2021
Approval ID
bcb4c886b8736685
Company
Sandoz Farmaceutica S.A.
Type
Standard
Approval Details
Approval Id
bcb4c886b8736685
Drug Cima Aemps Name
EZETIMIBA/ATORVASTATINA SANDOZ 10 MG/20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Register Number
86317
Holder Company Name
Sandoz Farmaceutica S.A.
Marketing Company Name
Sandoz Farmaceutica S.A.
Authorization Date
2021-12-09
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose
10 mg/20 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
Yes
Company Name
Sandoz Farmaceutica S.A.
Active Ingredients
EZETIMIBA
10 mg
ATORVASTATINA CALCICA TRIHIDRATO
21,69 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Dec 9, 2021
Approval ID
bcb4c886b8736685
Type
Standard
Back to CIMA-AEMPS Approvals